5-substituted deoxyuridines--structural requirements for antiviral activity against herpes simplex virus types 1 and 2 and possible biochemical basis for relative potency. 1984

I S Sim, and R H Raper

A number of structurally related 5-substituted pyrimidine 2'-deoxyribonucleosides were tested for antiviral activity against herpes simplex virus types 1 and 2 in cell culture. A minimum inhibitory concentration was determined for each compound and from a comparison of these values a number of conclusions were drawn with regard to those molecular features which enhance or reduce antiviral activity. Analogues in which the 5-substituent was unsaturated and conjugated with the pyrimidine ring were more potent antiviral drugs than the corresponding non-conjugated and alkyl-substituted analogues. The length of the 5-substituent and the nature of any heteroatoms contained within it also affected antiviral activity. When one pair of isomers was examined in more detail, differences in antiviral activity similar to those observed in cell culture occurred in virus-infected mice. The biochemical basis for the greater antiviral activity of the preferred isomer was related to affinity both for virus thymidine kinase and virus DNA polymerase.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013937 Thymidine Kinase An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5'-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. (From Enzyme Nomenclature, 1992) EC 2.7.1.21. Deoxythymidine Kinase,Deoxypyrimidine Kinase,Kinase, Deoxypyrimidine,Kinase, Deoxythymidine,Kinase, Thymidine
D018139 Simplexvirus A genus of the family HERPESVIRIDAE, subfamily ALPHAHERPESVIRINAE, consisting of herpes simplex-like viruses. The type species is HERPESVIRUS 1, HUMAN. Herpes Simplex Virus,Herpesvirus 1, Saimiriine,Herpesvirus 1, Saimirine,Herpesvirus 16, Cercopithecine,Marmoset Virus,Cercopithecine Herpesvirus 16,Herpes Labialis Virus,Herpes-T Virus,Herpesvirus 1 (alpha), Saimirine,Herpesvirus Hominis,Herpesvirus Papio 2,Herpesvirus Platyrhinae,Marmoset Herpesvirus,Saimiriine Herpesvirus 1,Herpes Labialis Viruses,Herpes Simplex Viruses,Herpes T Virus,Herpes-T Viruses,Herpesvirus Homini,Herpesvirus, Marmoset,Herpesviruses, Marmoset,Homini, Herpesvirus,Hominis, Herpesvirus,Labialis Virus, Herpes,Labialis Viruses, Herpes,Marmoset Herpesviruses,Marmoset Viruses,Platyrhinae, Herpesvirus,Saimirine Herpesvirus 1,Simplexviruses,Virus, Herpes Labialis,Viruses, Herpes Labialis

Related Publications

I S Sim, and R H Raper
January 1979, Advances in ophthalmology = Fortschritte der Augenheilkunde = Progres en ophtalmologie,
I S Sim, and R H Raper
January 1979, Voprosy virusologii,
I S Sim, and R H Raper
June 1991, Journal of medicinal chemistry,
I S Sim, and R H Raper
January 2022, Drug design, development and therapy,
Copied contents to your clipboard!